Clinical Trial Update: A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) [Phase 3]

View source ↗

Summary

Phase 3 trial of icatibant for acute attacks of hereditary angioedema completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2014-08-06